AKT1 and cancer: KEGG and GO enrichment analyses showed the potential impact of the “PI3K-Akt signaling pathway,” “ErbB signaling pathway,” “Focal adhesion,” and “Proteoglycans in cancer” or “EGFR tyrosine kinase inhibitor resistance” of cancers.